Biopartners Fund Ii Westlake News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biopartners fund ii westlake. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biopartners Fund Ii Westlake Today - Breaking & Trending Today

Acelyrin (NASDAQ:SLRN) Shares Up 5.3%

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) shares shot up 5.3% during trading on Friday . The stock traded as high as $22.94 and last traded at $22.94. 216,376 shares were traded during trading, a decline of 71% from the average session volume of 745,247 shares. The stock had previously closed at $21.78. Analyst Upgrades […] ....

Hidradenitis Suppurativa , Piper Sandler , Jefferies Financial Group , Morgan Stanley , Biopartners Fund Ii Westlake , Acelyrin Company Profile , Securities Exchange Commission , Acelyrin Inc , Get Free Report , Financial Group , Exchange Commission , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin (NASDAQ:SLRN) Stock Price Up 2.1%

Shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) rose 2.1% during trading on Thursday . The stock traded as high as $20.60 and last traded at $20.38. Approximately 83,507 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 828,472 shares. The stock had previously closed at $19.97. Analyst […] ....

Hidradenitis Suppurativa , Piper Sandler , Acelyrin Company Profile , Morgan Stanley , Acelyrin Inc , Biopartners Fund Ii Westlake , Jefferies Financial Group , Securities Exchange Commission , Free Report , Financial Group , Exchange Commission , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin, Inc.'s (NASDAQ:SLRN) Quiet Period To Expire Tomorrow

Acelyrin’s (NASDAQ:SLRN – Get Rating) quiet period will expire on Wednesday, June 14th. Acelyrin had issued 30,000,000 shares in its public offering on May 5th. The total size of the offering was $540,000,000 based on an initial share price of $18.00. During Acelyrin’s quiet period, underwriters and any insiders involved in the IPO are restricted […] ....

Agoura Hills , United States , Piper Sandler , Morgan Stanley , Jefferies Financial Group , Securities Exchange Commission , Biopartners Fund Ii Westlake , Acelyrin Inc , Acelyrin Company Profile , Get Rating , Financial Group , Exchange Commission , Acelyrin Daily ,

Acelyrin (NASDAQ:SLRN) Stock Price Up 7%

Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) rose 7% during trading on Thursday . The stock traded as high as $22.72 and last traded at $22.51. Approximately 233,153 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 1,164,579 shares. The stock had previously closed at $21.03. Acelyrin Price Performance […] ....

United States , Agoura Hills , Biopartners Fund Ii Westlake , Acelyrin Inc , Securities Exchange Commission , Get Rating , Exchange Commission , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin (NASDAQ:SLRN) Sets New 1-Year Low at $20.00

Shares of Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $20.00 and last traded at $20.03, with a volume of 12375 shares trading hands. The stock had previously closed at $20.72. Acelyrin Price Performance Insider Transactions at Acelyrin In related […] ....

United States , Agoura Hills , Bethc Seidenberg , Biopartners Fund Ii Westlake , Securities Exchange Commission , Acelyrin Inc , Get Rating , Director Beth , Exchange Commission , Acelyrin Daily , Nasdaq Slrn ,